P.411 The impact of age on sustained virological response in genotype 1 HIV-HCV co-infected patients receiving peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®): AIDS PEGASYS ribavirin co-infection trial (APRICOT)

Autor: Rockstroh, J., Torriani, F.J., Rodriguez Torres, M., Lissen, E., Lazzarin, A., De Pamphilis, J., Clumeck, N., Clotet, B., Sola, R., Dieterich, D.
Zdroj: In Journal of Clinical Virology 2006 36 Supplement 2:S187-S188
Databáze: ScienceDirect
Externí odkaz: